Squamous Cell Carcinoma is Highly Sensitive to Taxol, a Possible New Radiation Sensitizer (Q71877153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Squamous cell carcinoma is highly sensitive to taxol, a possible new radiation sensitizer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Squamous Cell Carcinoma is Highly Sensitive to Taxol, a Possible New Radiation Sensitizer (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.3109/00016489509139325

17 June 2024

main subject

squamous cell carcinoma

1 reference

1 reference

L. Elomaa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7610837

17 June 2024

H. Joensuu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7610837

17 June 2024

J. Kulmala

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7610837

17 June 2024

P. Klemi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7610837

17 June 2024

R. Grénman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7610837

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7610837

17 June 2024

publication date

1 March 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://www.tandfonline.com/doi/pdf/10.3109/00016489509139325

1 reference

Crossref

DOI

https://api.crossref.org/works/10.3109/00016489509139325

17 June 2024

published in

Acta Oto-Laryngologica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

340-344

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

Promotion of microtubule assembly in vitro by taxol

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Taxol: a novel investigational antimicrotubule agent

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Taxol stabilizes microtubules in mouse fibroblast cells

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Taxol sensitizes human ovarian cancer cells to radiation

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Taxol: a novel radiation sensitizer

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Taxol as a radiation sensitizer: a flow cytometric study.

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Comparison of fresh, ethanol-preserved, and paraffin-embedded samples in DNA flow cytometry

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

A Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

Carboplatin-radiation interaction in squamous cell carcinoma cell lines

17 June 2024

1 reference

https://api.crossref.org/works/10.3109/00016489509139325

17 June 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7610837%20AND%20SRC:MED&resulttype=core&format=json